Skip to main content
logo
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
8.13
-0.21 (-2.52%)
May 7, 2026, 3:04 PM EDT - Market open

Cartesian Therapeutics Revenue

Cartesian Therapeutics had revenue of $78.00K in the quarter ending March 31, 2026, a decrease of -92.91%. This brings the company's revenue in the last twelve months to $1.78M, down -94.81% year-over-year. In the year 2025, Cartesian Therapeutics had annual revenue of $2.80M, down -92.81%.

Revenue (ttm)
$1.78M
Revenue Growth
-94.81%
P/S Ratio
131.93
Revenue / Employee
$23,667
Employees
75
Market Cap
238.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.80M-36.12M-92.81%
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M68.48M412.60%
Dec 31, 202016.60M9.92M148.57%
Dec 31, 20196.68M5.77M639.42%
Dec 31, 2018903.00K696.00K336.23%
Dec 31, 2017207.00K-7.88M-97.44%
Dec 31, 20168.08M2.07M34.47%
Dec 31, 20156.01M2.97M97.73%
Dec 31, 20143.04M1.56M105.54%
Dec 31, 20131.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Keros Therapeutics244.06M
Heron Therapeutics154.90M
Codexis70.39M
Fennec Pharmaceuticals44.64M
Voyager Therapeutics40.37M
Orchestra BioMed Holdings33.48M
Sol-Gel Technologies19.39M
Adagene7.67M
Revenue Rankings

RNAC News

More News